The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold
MK Yates, KL Seley-Radtke - Antiviral research, 2019 - Elsevier
This is the second of two invited articles reviewing the development of nucleoside analogue
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold
MK Yates, KL Seley-Radtke - Antiviral research, 2019 - pubmed.ncbi.nlm.nih.gov
This is the second of two invited articles reviewing the development of nucleoside analogue
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
[HTML][HTML] The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold
MK Yates, KL Seley-Radtke - Antiviral Research, 2019 - ncbi.nlm.nih.gov
This is the second of two invited articles reviewing the development of nucleoside analogue
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold.
MK Yates, KL Seley-Radtke - Antiviral Research, 2018 - europepmc.org
This is the second of two invited articles reviewing the development of nucleoside analogue
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
[HTML][HTML] The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: complex modifications to the nucleoside scaffold
MK Yates, KL Seley-Radtke - Antiviral research, 2019 - ncbi.nlm.nih.gov
This is the second of two invited articles reviewing the development of nucleoside analogue
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold
MK Yates, KL Seley-Radtke - Antiviral research, 2019 - pubmed.ncbi.nlm.nih.gov
This is the second of two invited articles reviewing the development of nucleoside analogue
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold.
MK Yates, KL Seley-Radtke - Antiviral Research, 2018 - europepmc.org
This is the second of two invited articles reviewing the development of nucleoside analogue
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …